Is Accuray Incorporated (ARAY) a Buy, Sell, or Hold?
Accuray Incorporated
NASDAQ:ARAY
$0.264 USD
-$0.01 (-3.05%)
- Volume
- 0
- Average Volume
- 3.41M
- Market Capitalization
- $31.41M
- P/E Ratio
- -0.71
- Dividend Yield
- 0.00%
- Price Target
- $2.00
- Year High
- $2.10
- Year Low
- $0.24
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.42
Industry, Sector & symbol
| Stock Exchange | NASDAQ |
| CEO | Stephen R. LaNeve |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Current Symbol | ARAY |
| CUSIP | 004397105 |
| CIK | 0001138723 |
| Web | https://www.accuray.com |
| Phone | 608 824 2800 |
| Currency | USD |
| Employees | 990 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | 4.37 |
| Payout Ratio | 0.00 |
| Current Ratio | 1.42 |
| Quick Ratio | 0.66 |
| Cash Ratio | 0.18 |
Sales & Book Value
| Annual Sales | $458.5M |
| Price / Sales | 0.07 |
| Cash Flow | -0.23 |
| Price / Cash Flow | -1.08 |
| Price / Book | 0.79 |
Price Target and Rating
| Average Stock Price Forecast | $2.00 |
| High Stock Price Forecast | $2.00 |
| Low Stock Price Forecast | $2.00 |
| Forecast Upside/Downside | -86.80% |
| Consensus Rating | Strong Sell |
| Rating Score(0-5) | 1 |
| Research Coverage | 13 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-0.0155 |
| Trailing P/E Ratio | -0.71 |
| PEG Ratio | 0.00 |
| P/E Growth | 0.00 |
| Net Income | $-1.59M |
| Net Margin | -10.76% |
| Pretax Margin | -10.19% |
| Return on Equity | -77.48% |
| Return on Assets | -10.31% |
Financials Score
| AltmanZ Score | -0.65 |
| Piotroski Score | 2.00 |
| Working Capital | 87.37M |
| Total Assets | 447.6M |
| Ebit | -15.24M |
| Market Cap | 28.71M |
| Total Liabilities | 405.9M |
Poll Results
About Accuray Incorporated (NASDAQ:ARAY) Stock
Accuray Incorporated specializes in the design, development, production, and sale of advanced radiosurgery and radiation therapy equipment aimed at treating tumors. Their market footprint spans across North and South America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the broader Asia Pacific region. Among their core offerings is the CyberKnife System, a sophisticated robotic platform for stereotactic radiosurgery and stereotactic body radiation therapy. This system is employed to target both primary and metastatic tumors located outside the brain, specifically addressing areas such as the spine, breast, kidney, liver, lung, pancreas, and prostate. They also provide the TomoTherapy System, which encompasses the Radixact System, designed to deliver hig ... hly precise radiation treatments (up to 50 patients daily) through integrated planning, delivery, and data management capabilities. Complementing these are the iDMS data management system and the Accuray precision treatment planning system, both offering comprehensive solutions for treatment planning and data handling. In addition to their technology, Accuray offers crucial post-sale services, including customer support, system installation, training, and various other professional services. The company primarily engages directly with its clientele, which includes hospitals and specialized treatment centers, through its dedicated sales force. In the United States, they also leverage sales agents and group purchasing organizations, while internationally, their reach extends through distributors and sales agents. Established in 1990, Accuray Incorporated maintains its corporate headquarters in Madison, Wisconsin.
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
2026-05-29 16:10:00
MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new Chief Commercial Officer and David Shin, the company's new Chief Legal Officer.
2026-05-15 16:05:00
MADISON, Wis., May 15, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's Stellar™ adaptive radiation therapy platform.
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
2026-05-07 04:41:20
Accuray Incorporated (ARAY) Q3 2026 Earnings Call Transcript
Accuray Reports Fiscal 2026 Third Quarter Financial Results
2026-05-06 16:05:00
MADISON, Wis., May 6, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter ended March 31, 2026.
Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026
2026-04-22 16:05:00
MADISON, Wis., April 22, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m.
Accuray (ARAY) to Release Quarterly Earnings on Wednesday
2026-04-22 04:40:29
Accuray (NASDAQ: ARAY - Get Free Report) is anticipated to issue its Q3 2026 results after the market closes on Wednesday, April 29th. Analysts expect the company to announce earnings of ($0.05) per share and revenue of $111.90 million for the quarter. Parties are encouraged to explore the company's upcoming Q3 2026 earning overview page for
Frequently Asked Questions
-
What is the current Accuray Incorporated (ARAY) stock price?
-
Accuray Incorporated(NASDAQ:ARAY) stock price is $0.264 in the last trading session. During the trading session, ARAY stock reached the peak price of $2.1 while $0.24 was the lowest point it dropped to. The percentage change in ARAY stock occurred in the recent session was --3.05% while the dollar amount for the price change in ARAY stock was -$-0.01.
-
ARAY's industry and sector of operation?
-
The NASDAQ listed ARAY is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of ARAY?
-
Ali Pervaiz | Senior Vice President & Chief Financial Officer
John Dunn | Senior VP, Chief Information Officer
Michael J. Murphy | Corporate Controller & Principal Accounting Officer
Jim Dennison | Senior VP and Chief Quality & Regulatory Affairs Officer
Beth Kaplan | Public Relations Director -
How many employees does ARAY have?
-
Number of ARAY employees currently stands at 990. ARAY operates from 1240 Deming Way, Madison, WI 53717-1954, US.
-
Link for ARAY official website?
-
Official Website of ARAY is: https://www.accuray.com
-
How do I contact ARAY?
-
ARAY could be contacted at phone #608 824 2800 and can also be accessed through its website. ARAY operates from 1240 Deming Way, Madison, WI 53717-1954, US.
-
How many shares of ARAY are traded daily?
-
The average number of ARAY shares traded daily for last 3 months was 3.41M.
-
What is the market cap of ARAY currently?
-
The market value of ARAY currently stands at $31.41M with its latest stock price at $0.264